Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

ELI LILLY & Co Director's Dealing 2026

Feb 3, 2026

29745_dirs_2026-02-03_fc3536e6-3c8d-4245-9871-b738f9779ff2.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: ELI LILLY & Co (LLY)
CIK: 0000059478
Period of Report: 2026-02-01

Reporting Person: Yuffa Ilya (EVP&Pres, LLY USA&Global Capab)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2026-02-01 Common Stock M 3394 Acquired 29653.971 Direct
2026-02-01 Common Stock F 1512.364 $1037.15 Disposed 28141.607 Direct

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2026-02-01 Restricted Stock Unit $ M 3394 Disposed 2026-02-01 Common Stock (3394) Direct

Footnotes

F1: Each restricted stock unit represents a contingent right to receive one share of Eli Lilly and Company common stock.